ArticleThe oncologist2023

Radiotherapy Plus Temozolomide With or Without Nimotuzumab Against the Newly Diagnosed EGFR-Positive Glioblastoma: A Retrospective Cohort Study.

Lei She et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.